Milne Jill C.

Milne Jill C. is listed in filings as Director at BioCryst Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jun 2, 2026, including 9 public disclosures. Recent filings connect the profile to BioCryst Pharmaceuticals Inc (BCRX) and Astria Therapeutics, Inc. (ATXS). The current snapshot covers public activity from Mar 25, 2025 to Jun 2, 2026. Reported amounts are shown as $11.2K to $4.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.